REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Synthesis S.A.S (Colombia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorios Synthesis S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorios Synthesis Exercise is all business activities for the importation, exportation, manufacture, marketing, distribution and sale in Colombia or any country of pharmaceutical products, grooming.

Headquarters
Cra 44 No 20C 73
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Laboratorios Synthesis S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Synthesis S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorios Synthesis S.A.S report to view the information.
Registered Capital:
Purchase the Laboratorios Synthesis S.A.S report to view the information.
Incorporation Date:
March 23, 1972
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorios Synthesis S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.19%▲
Total operating revenue
18.17%▲
Operating profit (EBIT)
-64.94%▼
Net Profit (Loss) for the Period
420.57%▲
Total assets
1.99%▲
Total equity
9.24%▲
Operating Profit Margin (ROS)
-7.72%▼
Net Profit Margin
6.43%▲
Return on Equity (ROE)
7.74%▲
Debt to Equity Ratio
-0.46%▼
Quick Ratio
4.47%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo